IGI Logo

Fredun Pharmaceuticals is currently trading at Rs. 1405.70, up by 58.15 points or 4.32% from its previous closing of Rs. 1347.55 on the BSE.

The scrip opened at Rs. 1324.75 and has touched a high and low of Rs. 1410.00 and Rs. 1300.00 respectively. So far 9470 shares were traded on the counter.

The BSE group 'B' stock of face value Rs. 10 has touched a 52 week high of Rs. 1600.00 on 17-Aug-2026 and a 52 week low of Rs. 390.18 on 22-Sep-2025.

Last one week high and low of the scrip stood at Rs. 1,410.00 and Rs. 1193.35 respectively. The current market cap of the company is Rs. 2362.88 crore.

The promoters holding in the company stood at 44.57%, while Institutions and Non-Institutions held 4.00% and 51.43% respectively.

Fredun Pharmaceuticals has acquired a 26% stake in Goodman Vetcare marking a strategic step towards strengthening its presence in India’s animal health, veterinary retail and pet-care market. The association brings together Goodman's deep expertise and established retail network with Fredun Pharmaceuticals’ capabilities across healthcare, manufacturing, pet-care brands, technology and business development, creating a strong foundation for the next phase of growth. Together, the businesses will focus on expanding the brand’s footprint into new geographies while gradually strengthening its omnichannel capabilities.

For Goodman Vetcare, the association provides an opportunity to combine the trust, expertise and market relationships built over decades with the resources and capabilities required to scale further. For Fredun Pharmaceuticals, it adds an established customer-facing platform and specialised veterinary retail expertise to its growing healthcare and pet-care ecosystem. Together, the businesses aim to build on Goodman’s strong foundation, expand its reach and strengthen its position in India’s organised pet-health and veterinary retail market.